Spots Global Cancer Trial Database for Post-Marketing Surveillance of Gliadel 7.7mg Implant (All-case Observational Study)
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Post-Marketing Surveillance of Gliadel 7.7mg Implant (All-case Observational Study)
Official Title: Post-Marketing Surveillance of Gliadel 7.7mg Implant (All-case Observational Study)
Study ID: NCT02300532
Conditions
Interventions
Study Description
Brief Summary: Post-marketing surveillance to investigate the clinical safety and effectiveness in patients of all implantation of Gliadel with malignant glioma in the actual medical setting.
Detailed Description:
Eligibility
Minimum Age:
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
, Osaka, , Japan
, Tokyo, , Japan
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
